Literature DB >> 9364676

The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience.

B L Whittle1, N K Verma.   

Abstract

Attenuated, heterologous strains of Salmonella have shown potential as live, recombinant vaccines against foreign pathogens. Studies in animal models have demonstrated that immunization with these heterologous vaccines is an effective way to induce both cellular and humoral immune responses against Salmonella and the foreign antigen. We studied the consequence of priming mice with Salmonella dublin 3-6 months before intraperitoneal administration with the same strain carrying a model B-cell epitope. Mice primed with the carrier strain demonstrated enhanced serum Ig titres against the foreign antigen. This immune enhancement was observed up to approximately 6 months after priming. These findings suggest that previous immunological experience with Salmonella does not limit the immune response to a foreign antigen carried by the same organism. In fact, prior exposure to Salmonella appears to enhance the response to the foreign antigen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364676     DOI: 10.1016/s0264-410x(97)00119-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.

Authors:  J J Kohler; L Pathangey; A Hasona; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.

Authors:  C Jespersgaard; P Zhang; G Hajishengallis; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.

Authors:  J J Kohler; L B Pathangey; S R Gillespie; T A Brown
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.

Authors:  M Roberts; A Bacon; J Li; S Chatfield
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines.

Authors:  Tie Liu; Rolf König; Jian Sha; Stacy L Agar; Chien-Te K Tseng; Gary R Klimpel; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-06       Impact factor: 3.738

7.  Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter.

Authors:  Huaiqing Chen; Dieter M Schifferli
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.

Authors:  Christofer J Vindurampulle; Stephen R Attridge
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Vector priming reduces the immunogenicity of Salmonella-based vaccines in Nramp1+/+ mice.

Authors:  Christofer J Vindurampulle; Stephen R Attridge
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine.

Authors:  Manvendra Saxena; Peter J Coloe; Peter M Smooker
Journal:  Clin Vaccine Immunol       Date:  2008-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.